2 recruiting, 1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Stroke Prevention in Patients With Atrial Fibrillation: new trials by email Literature Review of Stroke Prevention in Patients With Atrial Fibrillation trials Research Report on Stroke Prevention in Patients With Atrial Fibrillation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study Dialysis, Chronic Kidney Disease (Stages 3b-5) | Not yet recruiting | Prince of Wales Hospital, Shatin, Hong Kong | 40 | 2026-12-05 | 2026-09-16 | |
| OPTION-EMEA Clinical Trial Concomitant pulsed field ablation (PFA) and left atrial appendage closure (LAAC) during one interventional case, Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure - Atrial Fibrillation (AF), Stroke Prevention in Patients With Atrial Fibrillation | Not applicable | Recruiting | Boston Scientific Corporation | 500 | 2026-06-18 | 2026-10-27 |
| CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention Left Atrial Appendage Closure, Apixaban 2.5 mg BID, Standard-dose DOAC - Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation | Recruiting | National Medical Research Center for Therapy and Preventive Medicine | 464 | 2026-04-01 | 2026-05-08 | |
| Long Term Open Follow-up With H376/95 vs. Warfarin EXANTA - Stroke Prevention in Patients With Atrial Fibrillation | Phase 2 | Terminated | AstraZeneca | 220 | 1999-08-01 | 2010-11-15 |
Atrial Fibrillation (3) · Hemorrhage (1) · Renal Insufficiency, Chronic (1) · Thromboembolism (1)
Arrhythmias, Cardiac (3) · Cardiovascular Diseases (3) · Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (1) · Disease Attributes (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Left Atrial Appendage Closure (2) · BID protein, human (1) · N(4)-oleylcytosine arabinoside (1) · apixaban (1) · ximelagatran (1)
AstraZeneca (1) · Boston Scientific Corporation (1) · National Medical Research Center for Therapy and Preventive Medicine (1) · Prince of Wales Hospital, Shatin, Hong Kong (1)
Belgium (2) · Croatia (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Hong Kong (1) · Italy (1) · Norway (1) · Poland (1) · Russia (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Karapet Davtyan, Professor (1) · Kent Chak Yu So, Clinical Assistant Professor (1)